Zimmer Biomet refines orthopedic focus, shares steady on NYSE
28.06.2026 - 09:50:45 | ad-hoc-news.de
By Christina Vogel, Background & Management desk. Reviewed prior to publication on 2026-06-28, 09:50.
Zimmer Biomet (US98956P1021) remains a key name in orthopedic devices on the NYSE, trading alongside larger sector peers such as Johnson & Johnson and Stryker in the S&P 500 healthcare cohort. The stock continues to be driven by demand for joint reconstruction procedures and hospital capital spending.
Zimmer Biomet’s position in orthopedics
Zimmer Biomet traces its roots to Zimmer Holdings and Biomet, which combined in 2015 to form a focused orthopedic and musculoskeletal company with global reach. The group competes with Stryker and Smith & Nephew in hip and knee implants, trauma devices and spine-related hardware.
The company reports revenues primarily from reconstructive products such as knee and hip systems, with additional contributions from sports medicine, extremities and dental solutions. Its portfolio is closely tied to procedure volumes in developed markets and an aging population in the United States, Europe and Asia.
Sector backdrop in US medical devices
The US-listed medical device sector features diversified players like Medtronic and Boston Scientific alongside more specialized firms such as Zimmer Biomet and Insulet. These companies benefit from steady demand for surgical procedures but face reimbursement scrutiny and competitive technology cycles.
Zimmer Biomet shares trade among S&P 500 healthcare constituents, many of which are monitored by major research houses such as Goldman Sachs and JPMorgan for sector-wide ratings and price-target changes. Analyst attention typically focuses on margins, innovation pace and hospital purchasing decisions.
Background and price data on Zimmer Biomet
Further news, figures and regulatory filings help investors follow the Zimmer Biomet shares over time.
The product behind the stock
Zimmer Biomet generates much of its revenue from knee replacement systems, including comprehensive implant families designed to replicate natural joint motion and support different surgical techniques. These systems are used in elective procedures worldwide and are supported by surgical instruments and digital planning tools.
The listing and current trading
The Zimmer Biomet shares (US98956P1021) trade on the NYSE under the ticker ZBH; the most recently reported closing price on MarketBeat on 2026-06-26 at 15:59 Eastern was 92.92 US dollars. Extended trading on the same date showed a price of 93.09 US dollars at 18:49 Eastern.
Key data on the Zimmer Biomet shares
- Company: Zimmer Biomet Holdings, Inc.
- ISIN: US98956P1021
- WKN: A1406Z
- Ticker: ZBH
- Trading venue: NYSE
- Price (as of 2026-06-26, 18:49 Eastern): 93.09 USD
- Market cap: 19.60 billion USD (as of 2026-06-26)
- Sector / industry: Health Care Equipment & Supplies
- Index membership: S&P 500
- Next earnings date: not officially scheduled
Disclaimer: This article is for informational purposes only and does not constitute investment advice, a recommendation or an offer to buy or sell securities.
